Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-42847922 crossover study in adults with insomnia disorder
2015-001672-22Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of seltorexant in Insomnia (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Sleep efficiency by polysomnography. Started Jun 2015; status: completed.
02
Drugs
seltorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2015-001672-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001672-22.